Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 open-label, dose-finding study of intravenous Ganaxolone in refractory status epilepticus patients

Next Previous
Trial Profile

A Phase 2 open-label, dose-finding study of intravenous Ganaxolone in refractory status epilepticus patients

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ganaxolone (Primary)
  • Indications Status epilepticus
  • Focus Proof of concept; Therapeutic Use

    • Most Recent Events

    • 24 Jun 2022 Results assessing the appropriate dosing for IV ganaxolone in RSE and obtain a preliminary assessment of efficacy and safety published in the Epilepsia
    • 09 Nov 2021 According to an Marinus Pharmaceuticals media release, data from this trial were presented during Neurocritical Care Society Annual Meeting in October.
    • 01 Sep 2021 Results assessing efficacy and safety of intravenous Ganaxolone in refractory status epilepticus patients, presented at the 34th International Epilepsy Congress.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top